Effects of Atenolol and Propranolol on Platelet Aggregation in Moderate Essential Hypertension: Randomized Crossover Trial

Punda, Ante; Polić, Stojan; Rumboldt, Zvonko; Bagatin, Jugoslav; Marković, Vinko; Lukin, Ajvor
April 2005
Croatian Medical Journal;2005, Vol. 46 Issue 2, p219
Academic Journal
Compares the effects of a selective beta-blocker atenolol and a nonselective beta-blocker propanolol on platelet aggregation. Role of platelet aggregation and arterial hypertension in the development of atherosclerosis; Methodology of the study; Discussion on the results of the study.


Related Articles

  • The Use of Beta-Adrenergic Blockers in the Treatment of Angina and Hypertension. Caris, Timothy N. // Angiology;Mar1986 Part 2, Vol. 37 Issue 3, p215 

    During the past decade, beta-adrenoreceptor blocking agents have proved to be valuable assets in our therapeutic armamentarium for management of both angina pectoris and essential hypertension. In ischemic heart disease, these agents reduce myocardial oxygen requirements by decreasing the force...

  • atenolol.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p207 

    A definition of the medical term "atenolol," which refers to a beta-blocking agent, is presented.

  • Hypertension Drugs and Waning Athletic Performance. Calhoun, Dave; Miller, Todd // Running & FitNews;Sep/Oct2008, Vol. 26 Issue 5, p20 

    The article provides an answer to a question on the health effects of hypertension drug called atenolol.

  • Most needy miss out on Î’-blockers.  // Pulse;10/4/2004, Vol. 64 Issue 39, p7 

    Reports that patients who would benefit most from beta blockers are least often receiving them in Great Britain. Conditions prevented by beta blockers.

  • Hypertension.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS43 

    Presents an abstract of the research manuscript `Evaluation of the anihypertensive and metabolic effects of atenolol and nebivolol in ambulatory hypertensive patients with glucose intolerance,' by L. Poirier, Y. Lacourciere and A. Nadeau. Cardioselective beta blockers.

  • Beta Blockers, lipids, and coronary atherosclerosis: fact or fiction? Northcote, Robin J. // British Medical Journal (Clinical Research Edition);3/12/1988, Vol. 296 Issue 6624, p731 

    Focuses on the relation between beta blockers, lipids, and coronary atherosclerosis. Impact of beta blockers on the plasma lipoprotein profile; Correlation between low total high density lipoprotein concentration and an increased risk of developing coronary disease; Effect of beta blockers in...

  • Antiarrhythmic Action of β-Blockers: Potential Mechanisms. Dorian, Paul // Journal of Cardiovascular Pharmacology & Therapeutics;Jun2005 Supplement, Vol. 10 Issue 2S, pS15 

    The article reports that multiple direct and indirect mechanisms of adrenergic action on the heart may benefit from the known antiarrhythmic actions of β-blocker therapy and other interventions that decrease sympathetic tone. The blockers in the heart are responsible for the primary direct...

  • Beta-blockers: Beyond cardiology. Daroff, Robert B.; Frishman, William H.; Lederman, Richard J.; Stewart, William C.; Millard, William B. // Patient Care;6/15/1993, Vol. 27 Issue 11, p47 

    Discusses the non-cardiologic uses of beta-blockers. List of beta-blockers approved for glaucoma; Complications of topical beta-blockers in the central nervous system; Factors considered in the administration of beta-blockers for migraine.

  • Does β-blocker prophylaxis improve survival after major noncardiac surgery? Terblanche, Marius; Adhikari, Neill K. J.; Scales, Damon C. // CMAJ: Canadian Medical Association Journal;10/11/2005, Vol. 173 Issue 8, p874 

    Presents a study on the relation of β-blockade therapy and the risk of death after major noncardiac surgery. Number of study participants; Limitations of the study; Implications of the study.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics